Detalhe da pesquisa
1.
Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo.
Mol Pharmacol
; 85(3): 429-40, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24342772
2.
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.
Proc Natl Acad Sci U S A
; 108(9): 3689-94, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21303985
3.
A novel Toll-like receptor 7/8-specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus.
Eur J Pharmacol
; 957: 175962, 2023 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544422
4.
Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
Cancer Immunol Immunother
; 61(1): 49-61, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21842208
5.
Assessment of the translational value of mouse lupus models using clinically relevant biomarkers.
Transl Res
; 163(6): 515-32, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24462761
6.
E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant.
Expert Rev Vaccines
; 6(5): 773-84, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17931157
7.
Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.
Clin Vaccine Immunol
; 14(11): 1499-504, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17715328
8.
Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice.
Vaccine
; 21(9-10): 961-70, 2003 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-12547609
9.
A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity.
J Pharmacol Exp Ther
; 300(2): 655-61, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11805229
10.
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-8684